Spirometer Flow Sensor Market Seen Hitting $1.55 Billion by 2030

The spirometer flow sensor market is projected to grow from $1 billion in 2025 to $1.55 billion by 2030, driven by rising respiratory disease rates, telemedicine adoption and demand for remote monitoring. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Spirometer flow sensors are becoming more important as healthcare systems look for earlier lung-disease detection and better long-term respiratory monitoring. - Rising demand for home care, telemedicine and connected medical devices is expanding use cases beyond traditional hospital testing. - The market’s projected rise to $1.55 billion by 2030 signals continued spending on respiratory diagnostics and digital health tools.

What happened: - The Business Research Company said the spirometer flow sensor market is expected to grow from $1 billion in 2025 to $1.09 billion in 2026. - The report projects the market will reach $1.55 billion by 2030, implying a 9.1% compound annual growth rate. - The company released the market outlook on July 22, 2026, with links to a free sample of the report and the full report. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period.

The details: - Historical growth has been supported by rising chronic respiratory illness rates, wider use of hospital pulmonary function tests, better awareness of early lung disease detection and the spread of basic digital spirometry technology. - Forecast growth is tied to remote respiratory monitoring, home healthcare, telemedicine, AI-assisted diagnostic precision, preventive respiratory screening and connected medical device integration. - The report highlights AI-powered respiratory diagnostics for real-time lung analysis, IoT-enabled spirometer sensors for remote patient monitoring, cloud-based pulmonary function testing, portable and handheld home-use devices and demand for high-accuracy digital airflow measurement in clinical settings. - A spirometer flow sensor measures the volume and speed of inhaled and exhaled air by converting airflow variations into electrical signals. - The sensor is used to assess respiratory function, measure airflow precisely and help detect lung abnormalities. - The report cites respiratory disease prevalence as a major demand driver. - Air pollution, including fine particulate matter, vehicle emissions and industrial smoke, is identified as a contributor to chronic breathing conditions and infections. - The report points to the UK Health Security Agency’s March 2025 update showing tuberculosis cases in England rose 13% in 2024 to 5,480 from 4,850 in 2023. - The report also cites UK Office for National Statistics data showing total healthcare expenditure rose 6.5% in nominal terms and 2.4% in real terms from 2023 to 2024. - UK government-funded healthcare spending reached $328 billion (£258 billion) in 2024, up 2.5% in real terms from the prior year. - The market coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, technology and trend analysis, and updated graphics and tables.

Between the lines: - The forecast suggests respiratory diagnostics are moving from episodic clinical testing toward continuous, connected monitoring. - The emphasis on AI, IoT and cloud platforms shows the market is shifting toward software-enabled hardware rather than stand-alone sensors. - Rising healthcare spending and higher respiratory disease burdens create a stronger buying environment for diagnostic devices, even as care moves closer to the patient.

What's next: - The market is expected to keep expanding through 2030 as remote monitoring and home-based respiratory care gain wider acceptance. - Adoption of portable devices and AI-enabled diagnostics could reshape how spirometer flow sensors are used in clinics and homes. - Regional growth in Asia-Pacific may narrow the gap with North America if healthcare investment and telemedicine adoption continue to accelerate.

The bottom line: - Spirometer flow sensors are moving into a larger, more connected respiratory care market, with growth driven by disease burden, digital diagnostics and expanding out-of-hospital care.